These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38533136)

  • 41. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
    Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
    Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of LDH in patients with coronavirus disease 2019 pneumonia.
    Mu T; Wang X; Lu Z; Tong J
    Front Cell Infect Microbiol; 2023; 13():1180187. PubMed ID: 37965268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
    Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
    Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
    Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
    Wu C; Chen X; Cai Y; Xia J; Zhou X; Xu S; Huang H; Zhang L; Zhou X; Du C; Zhang Y; Song J; Wang S; Chao Y; Yang Z; Xu J; Zhou X; Chen D; Xiong W; Xu L; Zhou F; Jiang J; Bai C; Zheng J; Song Y
    JAMA Intern Med; 2020 Jul; 180(7):934-943. PubMed ID: 32167524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
    Muller M; Lefebvre F; Harlay ML; Glady L; Becker G; Muller C; Aberkane O; Tawk M; Julians M; Romoli A; Hecketsweiler S; Schneider F; Pottecher J; Chamaraux-Tran TN
    Trials; 2021 Feb; 22(1):131. PubMed ID: 33573681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
    Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
    Front Immunol; 2021; 12():627548. PubMed ID: 33777012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of Annexin-1 (ANXA-1), Annexin-2 (ANXA-2) and Bone Morphogenetic Protein-7 (BMP-7) Serum Levels in Patients Followed Up With A Diagnosis of COVID-19].
    Ural O; Kıratlı HE; Sümer Ş; Aktuğ Demir N; Yılmaz Kırık S; Vatansev H; Akyürek F; Cebeci H; Arslan U; Demir LS
    Mikrobiyol Bul; 2022 Jan; 56(1):25-35. PubMed ID: 35088957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Inflammatory Markers with Mortality in COVID-19 Infection.
    Arshad AR; Khan I; Shahzad K; Arshad M; Haider SJ; Aslam MJ
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):158-163. PubMed ID: 33291195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute respiratory failure in COVID-19: is it "typical" ARDS?
    Li X; Ma X
    Crit Care; 2020 May; 24(1):198. PubMed ID: 32375845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presepsin as a Novel Biomarker in predicting In-hospital Mortality in Patients With COVID-19 Pneumonia.
    Assal HH; Abdelrahman SM; Abdelbasset MA; Abdelaziz M; Sabry IM; Shaban MM
    Int J Infect Dis; 2022 May; 118():155-163. PubMed ID: 35248717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by
    El-Hefnawy SM; Eid HA; Mostafa RG; Soliman SS; Omar TA; Azmy RM
    Gene Rep; 2022 Jun; 27():101612. PubMed ID: 35463461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
    Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
    Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
    Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
    Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
    Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
    Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.